MRD / Regn No. : 20210000409 Date : 21/07/2026
Patient Name : Anuradha Sancheti Kishore Age & Gender : 47 Yrs. / Female
Contact No. : 8111008070 UHID :
Ht / Wt / BMI : 168 / 112 / 39.68 BP S / BP D : 160 / 100
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (22/Apr/2013) | HYPOTHYROIDISM (11/Sep/1998) | OBESITY (12/Feb/2013) | DYSSOMNIA (06/May/2024) |
Subjective : IRREGULAR FOLLOW UP
Objective : NO THYROMEGALY
Analysis : OBESITY,HYPOTHYROIDISM UNDER REPLACED,DYSSOMNNIA,HYPERTENSION,VCDR > 0.2,TYPE 2 DM UNCONTROLLED
Plan : INCREASE SEMBOLIC TO 2.4 MG,ADD JARDIANCE,SEE ME IN 1 MONTH  
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET IMEGLIMIN 1000 MG
IMEXTOR
Medicine For GLUCOSE CONTROL
PO 1-0-1 BEFORE FOOD
TILL NEXT VISIT
2 TABLET GLICLAZIDE XR 60 MG
CYBLEX XR 60 MG
Medicine For GLUCOSE CONTROL
PO 1-0-0 BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE LOW SUGARS
3 INJECTION SEMAGLUTIDE
SEMBOLIC 2.4 MG
Medicine For DIABETES OBESITY
SQ ONCE A WEEK AS DIRECTED NO RELATION TO MEALS
TILL NEXT VISIT
MAY CAUSE GI AND VISUAL DISTURBANCES
4 SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION
PO 1-0-0 BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTIONS
       
Refill : 0 / Substitution:    
Education : THERE ARE EXTREMELY RARE REPORTS OF VISION PROBLEMS WITH SEMAGLUTIDE PLEASE INFORM US IF THERE IS VISUAL DISTURBANCE
Next Visit : 20/Aug/2026
Tests Suggested For Next Visit : FBS 2HPP
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: